Literature DB >> 15120361

Is gastric bypass superior for the surgical treatment of obesity compared with malabsorptive procedures?

Eric J DeMaria1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15120361     DOI： 10.1016/j.gassur.2003.12.022

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  6 in total

Review 1.  Surgery for morbid obesity.

Authors:  John M H Bennett; Samir Mehta; Michael Rhodes
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

2.  Temporary restoration of digestive continuity after laparoscopic gastric bypass to allow endoscopic sphincterotomy and retrograde exploration of the biliary tract.

Authors:  Arnaud Saget; Enrico Facchiano; Pierre-Olivier Bosset; Benjamin Castel; Philippe Ruszniewski; Simon Msika
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

3.  Wernicke's encephalopathy after laparoscopic Roux-en-Y gastric bypass: a misdiagnosed complication.

Authors:  Antonio Iannelli; Pietro Addeo; Sebastien Novellas; Jean Gugenheim
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

4.  Internal hernia as a complication of laparoscopic Roux-en-Y gastric bypass.

Authors:  Antonio Iannelli; Massimo Senni Buratti; Sebastian Novellas; Moucef Dahman; Imed Ben Amor; Eric Sejor; Enrico Facchiano; Pietro Addeo; Jean Gugenheim
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

5.  Laparoscopic conversion of vertical banded gastroplasty (Mason MacLean) into Roux-en-Y gastric bypass.

Authors:  Antonio Iannelli; Daniela Amato; Pietro Addeo; Massimo Senni Buratti; Moucef Damhan; Imed Ben Amor; Eric Sejor; Enrico Facchiano; Jean Gugenheim
Journal:  Obes Surg       Date:  2007-12-15       Impact factor: 4.129

6.  Conversion of failed vertical banded gastroplasty to biliopancreatic diversion, a wise option.

Authors:  Markos Daskalakis; Oliver Scheffel; Sophia Theodoridou; Rudolf A Weiner
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.